Home > > > Report Detail

Global (United States, European Union and China) Hormone Refractory Prostate Cancer (HRPCA) Market Research Report 2019-2025

Publisher Name :
Date: 02-Aug-2019
No. of pages: 113
Inquire Before Buying

Hormone Refractory Prostate Cancer (HRPCA) or Castrate-Resistant Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after having hormonal therapy, is now under the spotlight in prostate cancer market. Due to the high unmet clinical need associated with limited survival periods, intensifying HRPCA prevalence and fast-emerging treatment modifications, the global HRPCA market is poised to witness an unprecedented growth.

In 2019, the market size of Hormone Refractory Prostate Cancer (HRPCA) is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.

In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Hormone Refractory Prostate Cancer (HRPCA).

This report studies the global market size of Hormone Refractory Prostate Cancer (HRPCA), especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).

This study presents the Hormone Refractory Prostate Cancer (HRPCA) sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.

For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:

- Astellas Inc

- Sanofi S.A

- Dendreon Corporation, Bayer AG

- Johnson & Johnson

- ...

Market Segment by Product Type

- Chemotherapy

- Hormonal Therapy

- Immunotherapy

- Radiation Therapy

- Surgery

Market Segment by Application

- Hospitals

- Ambulatory Surgical Centers

- Specialty Clinics

Key Regions split in this report: breakdown data for each region.

- United States

- China

- European Union

- Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:

- To analyze and research the Hormone Refractory Prostate Cancer (HRPCA) status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.

- To present the key Hormone Refractory Prostate Cancer (HRPCA) manufacturers, presenting the sales, revenue, market share, and recent development for key players.

- To split the breakdown data by regions, type, companies and applications

- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

- To identify significant trends, drivers, influence factors in global and regions

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Hormone Refractory Prostate Cancer (HRPCA) are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

Global (United States, European Union and China) Hormone Refractory Prostate Cancer (HRPCA) Market Research Report 2019-2025

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Hormone Refractory Prostate Cancer (HRPCA) Market Size Growth Rate by Type (2019-2025)
1.3.2 Chemotherapy
1.3.3 Hormonal Therapy
1.3.4 Immunotherapy
1.3.5 Radiation Therapy
1.3.6 Surgery
1.4 Market Segment by Application
1.4.1 Global Hormone Refractory Prostate Cancer (HRPCA) Market Share by Application (2019-2025)
1.4.2 Hospitals
1.4.3 Ambulatory Surgical Centers
1.4.4 Specialty Clinics
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hormone Refractory Prostate Cancer (HRPCA) Market Size
2.1.1 Global Hormone Refractory Prostate Cancer (HRPCA) Revenue 2014-2025
2.1.2 Global Hormone Refractory Prostate Cancer (HRPCA) Sales 2014-2025
2.2 Hormone Refractory Prostate Cancer (HRPCA) Growth Rate by Regions
2.2.1 Global Hormone Refractory Prostate Cancer (HRPCA) Sales by Regions 2014-2019
2.2.2 Global Hormone Refractory Prostate Cancer (HRPCA) Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Hormone Refractory Prostate Cancer (HRPCA) Sales by Manufacturers
3.1.1 Hormone Refractory Prostate Cancer (HRPCA) Sales by Manufacturers 2014-2019
3.1.2 Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Hormone Refractory Prostate Cancer (HRPCA) Revenue by Manufacturers (2014-2019)
3.2.2 Hormone Refractory Prostate Cancer (HRPCA) Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Hormone Refractory Prostate Cancer (HRPCA) Market Concentration Ratio (CR5 and HHI)
3.3 Hormone Refractory Prostate Cancer (HRPCA) Price by Manufacturers
3.4 Key Manufacturers Hormone Refractory Prostate Cancer (HRPCA) Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Hormone Refractory Prostate Cancer (HRPCA) Market
3.6 Key Manufacturers Hormone Refractory Prostate Cancer (HRPCA) Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Chemotherapy Sales and Revenue (2014-2019)
4.1.2 Hormonal Therapy Sales and Revenue (2014-2019)
4.1.3 Immunotherapy Sales and Revenue (2014-2019)
4.1.4 Radiation Therapy Sales and Revenue (2014-2019)
4.1.5 Surgery Sales and Revenue (2014-2019)
4.2 Global Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Type
4.3 Global Hormone Refractory Prostate Cancer (HRPCA) Revenue Market Share by Type
4.4 Hormone Refractory Prostate Cancer (HRPCA) Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Hormone Refractory Prostate Cancer (HRPCA) Sales by Application
6 United States
6.1 United States Hormone Refractory Prostate Cancer (HRPCA) Breakdown Data by Company
6.2 United States Hormone Refractory Prostate Cancer (HRPCA) Breakdown Data by Type
6.3 United States Hormone Refractory Prostate Cancer (HRPCA) Breakdown Data by Application
7 European Union
7.1 European Union Hormone Refractory Prostate Cancer (HRPCA) Breakdown Data by Company
7.2 European Union Hormone Refractory Prostate Cancer (HRPCA) Breakdown Data by Type
7.3 European Union Hormone Refractory Prostate Cancer (HRPCA) Breakdown Data by Application
8 China
8.1 China Hormone Refractory Prostate Cancer (HRPCA) Breakdown Data by Company
8.2 China Hormone Refractory Prostate Cancer (HRPCA) Breakdown Data by Type
8.3 China Hormone Refractory Prostate Cancer (HRPCA) Breakdown Data by Application
9 Rest of World
9.1 Rest of World Hormone Refractory Prostate Cancer (HRPCA) Breakdown Data by Company
9.2 Rest of World Hormone Refractory Prostate Cancer (HRPCA) Breakdown Data by Type
9.3 Rest of World Hormone Refractory Prostate Cancer (HRPCA) Breakdown Data by Application
9.4 Rest of World Hormone Refractory Prostate Cancer (HRPCA) Breakdown Data by Countries
9.4.1 Rest of World Hormone Refractory Prostate Cancer (HRPCA) Sales by Countries
9.4.2 Rest of World Hormone Refractory Prostate Cancer (HRPCA) Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Astellas Inc
10.1.1 Astellas Inc Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Hormone Refractory Prostate Cancer (HRPCA)
10.1.4 Hormone Refractory Prostate Cancer (HRPCA) Product Introduction
10.1.5 Astellas Inc Recent Development
10.2 Sanofi S.A
10.2.1 Sanofi S.A Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Hormone Refractory Prostate Cancer (HRPCA)
10.2.4 Hormone Refractory Prostate Cancer (HRPCA) Product Introduction
10.2.5 Sanofi S.A Recent Development
10.3 Dendreon Corporation, Bayer AG
10.3.1 Dendreon Corporation, Bayer AG Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Hormone Refractory Prostate Cancer (HRPCA)
10.3.4 Hormone Refractory Prostate Cancer (HRPCA) Product Introduction
10.3.5 Dendreon Corporation, Bayer AG Recent Development
10.4 Johnson & Johnson
10.4.1 Johnson & Johnson Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Hormone Refractory Prostate Cancer (HRPCA)
10.4.4 Hormone Refractory Prostate Cancer (HRPCA) Product Introduction
10.4.5 Johnson & Johnson Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Hormone Refractory Prostate Cancer (HRPCA) Sales Channels
11.2.2 Hormone Refractory Prostate Cancer (HRPCA) Distributors
11.3 Hormone Refractory Prostate Cancer (HRPCA) Customers
12 Market Forecast
12.1 Global Hormone Refractory Prostate Cancer (HRPCA) Sales and Revenue Forecast 2019-2025
12.2 Global Hormone Refractory Prostate Cancer (HRPCA) Sales Forecast by Type
12.3 Global Hormone Refractory Prostate Cancer (HRPCA) Sales Forecast by Application
12.4 Hormone Refractory Prostate Cancer (HRPCA) Forecast by Regions
12.4.1 Global Hormone Refractory Prostate Cancer (HRPCA) Sales Forecast by Regions 2019-2025
12.4.2 Global Hormone Refractory Prostate Cancer (HRPCA) Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables and Figures
Figure Hormone Refractory Prostate Cancer (HRPCA) Product Picture
Table Hormone Refractory Prostate Cancer (HRPCA) Key Market Segments
Table Major Manufacturers Hormone Refractory Prostate Cancer (HRPCA) Covered in This Report
Table Global Hormone Refractory Prostate Cancer (HRPCA) Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$)
Figure Global Hormone Refractory Prostate Cancer (HRPCA) Sales Market Shar by Type 2014-2025
Figure Chemotherapy Figures
Table Major Manufacturers of Chemotherapy
Figure Hormonal Therapy Figures
Table Major Manufacturers of Hormonal Therapy
Figure Immunotherapy Figures
Table Major Manufacturers of Immunotherapy
Figure Radiation Therapy Figures
Table Major Manufacturers of Radiation Therapy
Figure Surgery Figures
Table Major Manufacturers of Surgery
Table Global Hormone Refractory Prostate Cancer (HRPCA) Market Share by Application 2019-2025 (K Units)
Figure Hospitals Use Case
Figure Ambulatory Surgical Centers Use Case
Figure Specialty Clinics Use Case
Figure Hormone Refractory Prostate Cancer (HRPCA) Report Years Considered
Figure Global Hormone Refractory Prostate Cancer (HRPCA) Market Size 2014-2025 (Million US$)
Figure Global Hormone Refractory Prostate Cancer (HRPCA) Sales 2014-2019 (K Units)
Table Global Hormone Refractory Prostate Cancer (HRPCA) Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Hormone Refractory Prostate Cancer (HRPCA) Sales by Regions 2014-2019 (K Units)
Table Global Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Regions 2014-2019
Figure Global Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Regions 2014-2019
Figure Global Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Regions in 2019
Table Global Hormone Refractory Prostate Cancer (HRPCA) Revenue by Regions 2014-2019 (Million US$)
Table Global Hormone Refractory Prostate Cancer (HRPCA) Revenue Market Share by Regions 2014-2019
Figure Global Hormone Refractory Prostate Cancer (HRPCA) Revenue Market Share by Regions 2014-2019
Figure Global Hormone Refractory Prostate Cancer (HRPCA) Revenue Market Share by Regions in 2019
Table Market Top Trends
Table Global Hormone Refractory Prostate Cancer (HRPCA) Sales by Manufacturers (2014-2019) (K Units)
Table Global Hormone Refractory Prostate Cancer (HRPCA) Sales Share by Manufacturers (2014-2019)
Figure Global Hormone Refractory Prostate Cancer (HRPCA) Sales Share by Manufacturers in 2019
Table Hormone Refractory Prostate Cancer (HRPCA) Revenue by Manufacturers (2014-2019) (Million USD)
Table Hormone Refractory Prostate Cancer (HRPCA) Revenue Share by Manufacturers (2014-2019)
Figure Hormone Refractory Prostate Cancer (HRPCA) Value Share by Manufacturers in 2019
Table Global Hormone Refractory Prostate Cancer (HRPCA) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Hormone Refractory Prostate Cancer (HRPCA) Price (2014-2019) (USD/Unit)
Table Key Manufacturers Hormone Refractory Prostate Cancer (HRPCA) Plants/Factories Distribution
Table Key Manufacturers Hormone Refractory Prostate Cancer (HRPCA) Area Served
Table Date of Key Manufacturers Enter into Hormone Refractory Prostate Cancer (HRPCA) Market
Table Key Manufacturers Hormone Refractory Prostate Cancer (HRPCA) Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Chemotherapy Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Hormonal Therapy Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Immunotherapy Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Radiation Therapy Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Surgery Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Hormone Refractory Prostate Cancer (HRPCA) Sales by Type (2014-2019) (K Units)
Table Global Hormone Refractory Prostate Cancer (HRPCA) Sales Share by Type (2014-2019)
Figure Global Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Type (2014-2019)
Figure Global Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Type in 2018
Table Global Hormone Refractory Prostate Cancer (HRPCA) Revenue by Type (2014-2019) (Million US$)
Table Global Hormone Refractory Prostate Cancer (HRPCA) Revenue Share by Type (2014-2019)
Figure Global Hormone Refractory Prostate Cancer (HRPCA) Revenue Market Share by Type (2014-2019)
Figure Global Hormone Refractory Prostate Cancer (HRPCA) Revenue Market Share by Type in 2018
Table Hormone Refractory Prostate Cancer (HRPCA) Price by Type 2014-2019 (USD/Unit)
Table Global Hormone Refractory Prostate Cancer (HRPCA) Sales by Application (2014-2019) (K Units)
Table Global Hormone Refractory Prostate Cancer (HRPCA) Sales Share by Application (2014-2019)
Figure Global Sales Hormone Refractory Prostate Cancer (HRPCA) Market Share by Application (2014-2019)
Figure Global Sales Hormone Refractory Prostate Cancer (HRPCA) Market Share by Application (2014-2019)
Figure United States Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate 2014-2019 (K Units)
Figure United States Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate 2014-2019 (Million US$)
Table United States Hormone Refractory Prostate Cancer (HRPCA) Sales by Company (2014-2019) (K Units)
Table United States Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Company (2014-2019)
Figure United States Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Company in 2019
Table United States Hormone Refractory Prostate Cancer (HRPCA) Sales by Type (2014-2019) (K Units)
Table United States Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Type (2014-2019)
Figure United States Hormone Refractory Prostate Cancer (HRPCA) Market Share by Type in 2019
Table United States Hormone Refractory Prostate Cancer (HRPCA) Sales by Application (2014-2019) (K Units)
Table United States Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Application (2014-2019)
Figure United States Hormone Refractory Prostate Cancer (HRPCA) Market Share by Application in 2019
Figure European Union Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate 2014-2019 (K Units)
Figure European Union Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate 2014-2019 (Million US$)
Table European Union Hormone Refractory Prostate Cancer (HRPCA) Sales by Company (2014-2019) (K Units)
Table European Union Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Company (2014-2019)
Figure European Union Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Company in 2019
Table European Union Hormone Refractory Prostate Cancer (HRPCA) Sales by Type (2014-2019) (K Units)
Table European Union Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Type (2014-2019)
Figure 2018 European Union Hormone Refractory Prostate Cancer (HRPCA) Market Share by Type
Table European Union Hormone Refractory Prostate Cancer (HRPCA) Sales by Application (2014-2019) (K Units)
Table European Union Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Application (2014-2019)
Figure 2018 European Union Hormone Refractory Prostate Cancer (HRPCA) Market Share by Application
Figure China Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate 2014-2019 (K Units)
Figure China Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate 2014-2019 (Million US$)
Table China Hormone Refractory Prostate Cancer (HRPCA) Sales by Company (2014-2019) (K Units)
Table China Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Company (2014-2019)
Figure China Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Company in 2019
Table China Hormone Refractory Prostate Cancer (HRPCA) Sales by Type (2014-2019) (K Units)
Table China Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Type (2014-2019)
Figure China Hormone Refractory Prostate Cancer (HRPCA) Market Share by Type in 2019
Table China Hormone Refractory Prostate Cancer (HRPCA) Sales by Application (2014-2019) (K Units)
Table China Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Application (2014-2019)
Figure China Hormone Refractory Prostate Cancer (HRPCA) Market Share by Application in 2019
Figure Rest of World Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate 2014-2019 (K Units)
Figure Rest of World Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate 2014-2019 (Million US$)
Table Rest of World Hormone Refractory Prostate Cancer (HRPCA) Sales by Company (2014-2019) (K Units)
Table Rest of World Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Company (2014-2019)
Figure Rest of World Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Company in 2019
Table Rest of World Hormone Refractory Prostate Cancer (HRPCA) Sales by Type (2014-2019) (K Units)
Table Rest of World Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Type (2014-2019)
Figure Rest of World Hormone Refractory Prostate Cancer (HRPCA) Market Share by Type in 2019
Table Rest of World Hormone Refractory Prostate Cancer (HRPCA) Sales by Application (2014-2019) (K Units)
Table Rest of World Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Application (2014-2019)
Figure Rest of World Hormone Refractory Prostate Cancer (HRPCA) Market Share by Application in 2019
Table Rest of World Hormone Refractory Prostate Cancer (HRPCA) Sales by Countries (2014-2019) (K Units)
Table Rest of World Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Countries (2014-2019)
Figure Rest of World Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Countries in 2019
Table Rest of World Hormone Refractory Prostate Cancer (HRPCA) Revenue by Countries (2014-2019) (Million US$)
Table Rest of World Hormone Refractory Prostate Cancer (HRPCA) Revenue Market Share by Countries (2014-2019)
Figure Rest of World Hormone Refractory Prostate Cancer (HRPCA) Revenue Market Share by Countries in 2019
Figure Japan Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate (2014-2019) (K Units)
Figure Japan Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate (2014-2019) (K Units)
Figure Korea Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate (2014-2019) (K Units)
Figure Korea Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate (2014-2019) (K Units)
Figure India Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate (2014-2019) (K Units)
Figure India Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate (2014-2019) (K Units)
Figure Southeast Asia Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate (2014-2019) (K Units)
Figure Southeast Asia Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate (2014-2019) (K Units)
Table Astellas Inc Company Details
Table Astellas Inc Description and Business Overview
Table Astellas Inc Hormone Refractory Prostate Cancer (HRPCA) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Astellas Inc Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate (2014-2019)
Table Astellas Inc Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share in Global Market
Table Astellas Inc Recent Development
Table Sanofi S.A Company Details
Table Sanofi S.A Description and Business Overview
Table Sanofi S.A Hormone Refractory Prostate Cancer (HRPCA) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi S.A Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate (2014-2019)
Table Sanofi S.A Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share in Global Market
Table Sanofi S.A Recent Development
Table Dendreon Corporation, Bayer AG Company Details
Table Dendreon Corporation, Bayer AG Description and Business Overview
Table Dendreon Corporation, Bayer AG Hormone Refractory Prostate Cancer (HRPCA) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Dendreon Corporation, Bayer AG Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate (2014-2019)
Table Dendreon Corporation, Bayer AG Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share in Global Market
Table Dendreon Corporation, Bayer AG Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Description and Business Overview
Table Johnson & Johnson Hormone Refractory Prostate Cancer (HRPCA) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Johnson & Johnson Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate (2014-2019)
Table Johnson & Johnson Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share in Global Market
Table Johnson & Johnson Recent Development
Figure Hormone Refractory Prostate Cancer (HRPCA) Value Chain
Table Hormone Refractory Prostate Cancer (HRPCA) Distributors List
Table Hormone Refractory Prostate Cancer (HRPCA) Customers List
Table Global Hormone Refractory Prostate Cancer (HRPCA) Sales Forecast 2019-2025 (K Units) & (Million US$)
Figure Global Hormone Refractory Prostate Cancer (HRPCA) Sales Forecast 2019-2025 (K Units)
Figure Global Hormone Refractory Prostate Cancer (HRPCA) Revenue Forecast 2019-2025 (Million US$)
Table Global Hormone Refractory Prostate Cancer (HRPCA) Sales Forecast by Type 2019-2025 (K Units)
Figure Global Hormone Refractory Prostate Cancer (HRPCA) Sales Forecast by Type 2019-2025 (K Units)
Figure Global Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share Forecast by Type 2019-2025
Table Global Hormone Refractory Prostate Cancer (HRPCA) Sales Forecast by Application 2019-2025 (K Units)
Figure Global Hormone Refractory Prostate Cancer (HRPCA) Sales Forecast by Application 2019-2025 (K Units)
Figure Global Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share Forecast by Application 2019-2025
Table Global Hormone Refractory Prostate Cancer (HRPCA) Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Hormone Refractory Prostate Cancer (HRPCA) Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share Forecast by Regions 2019-2025
Table Global Hormone Refractory Prostate Cancer (HRPCA) Revenue Forecast by Regions 2019-2025 (K Units)
Figure Global Hormone Refractory Prostate Cancer (HRPCA) Revenue Forecast by Regions 2019-2025 (K Units)
Figure Global Hormone Refractory Prostate Cancer (HRPCA) Revenue Market Share Forecast by Regions 2019-2025
Figure United States Hormone Refractory Prostate Cancer (HRPCA) Sales Forecast 2019-2025 (K Units)
Figure United States Hormone Refractory Prostate Cancer (HRPCA) Revenue Forecast 2019-2025 (Million US$)
Figure European Union Hormone Refractory Prostate Cancer (HRPCA) Sales Forecast 2019-2025 (K Units)
Figure European Union Hormone Refractory Prostate Cancer (HRPCA) Revenue Forecast 2019-2025 (Million US$)
Figure China Hormone Refractory Prostate Cancer (HRPCA) Sales Forecast 2019-2025 (K Units)
Figure China Hormone Refractory Prostate Cancer (HRPCA) Revenue Forecast 2019-2025 (Million US$)
Figure Japan Hormone Refractory Prostate Cancer (HRPCA) Sales Forecast 2019-2025 (K Units)
Figure Japan Hormone Refractory Prostate Cancer (HRPCA) Revenue Forecast 2019-2025 (Million US$)
Figure Korea Hormone Refractory Prostate Cancer (HRPCA) Sales Forecast 2019-2025 (K Units)
Figure Korea Hormone Refractory Prostate Cancer (HRPCA) Revenue Forecast 2019-2025 (Million US$)
Figure India Hormone Refractory Prostate Cancer (HRPCA) Sales Forecast 2019-2025 (K Units)
Figure India Hormone Refractory Prostate Cancer (HRPCA) Revenue Forecast 2019-2025 (Million US$)
Figure Southeast Asia Hormone Refractory Prostate Cancer (HRPCA) Sales Forecast 2019-2025 (K Units)
Figure Southeast Asia Hormone Refractory Prostate Cancer (HRPCA) Revenue Forecast 2019-2025 (Million US$)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs